- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Metastatic Merkel cell carcinoma response to nivolumab ; volume:4 ; number:1 ; day:15 ; month:11 ; year:2016 ; pages:1-4 ; date:12.2016
Journal for ImmunoTherapy of Cancer ; 4, Heft 1 (15.11.2016), 1-4, 12.2016
- Creator
-
Walocko, Frances M.
- Contributor
-
Scheier, Benjamin Y.
Harms, Paul W.
Fecher, Leslie A.
Lao, Christopher D.
SpringerLink (Online service)
- DOI
-
10.1186/s40425-016-0186-1
- URN
-
urn:nbn:de:1111-201612048360
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Walocko, Frances M.
- Scheier, Benjamin Y.
- Harms, Paul W.
- Fecher, Leslie A.
- Lao, Christopher D.
- SpringerLink (Online service)
Other Objects (12)
Erratum to: Metastatic Merkel cell carcinoma response to nivolumab
Nivolumab for Metastatic Cutaneous Squamous Cell Carcinoma
Immunomodulatory response to neoadjuvant nivolumab in non-metastatic clear cell renal cell carcinoma
Immune-Related Meningoencephalitis following Nivolumab in Metastatic Renal Cell Carcinoma
Response to anti-PD1 therapy with nivolumab in metastatic sarcomas
Activity of ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma
Activity of ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma
Significant response to nivolumab for metastatic chromophobe renal cell carcinoma with sarcomatoid differentiation: a case report
Successful Treatment with Nivolumab in a Patient with Metastatic Salivary Duct Carcinoma
Metastatic Merkel Cell Carcinoma of the Abdominal Wall
Cost Effectiveness of Avelumab for Metastatic Merkel Cell Carcinoma
Challenges of New Approaches in Metastatic Merkel Cell Carcinoma
Erratum to: Metastatic Merkel cell carcinoma response to nivolumab
Nivolumab for Metastatic Cutaneous Squamous Cell Carcinoma
Immunomodulatory response to neoadjuvant nivolumab in non-metastatic clear cell renal cell carcinoma
Immune-Related Meningoencephalitis following Nivolumab in Metastatic Renal Cell Carcinoma
Response to anti-PD1 therapy with nivolumab in metastatic sarcomas
Activity of ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma
Activity of ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma
Significant response to nivolumab for metastatic chromophobe renal cell carcinoma with sarcomatoid differentiation: a case report
Successful Treatment with Nivolumab in a Patient with Metastatic Salivary Duct Carcinoma
Metastatic Merkel Cell Carcinoma of the Abdominal Wall
Cost Effectiveness of Avelumab for Metastatic Merkel Cell Carcinoma
Challenges of New Approaches in Metastatic Merkel Cell Carcinoma
Erratum to: Metastatic Merkel cell carcinoma response to nivolumab
Nivolumab for Metastatic Cutaneous Squamous Cell Carcinoma
Immunomodulatory response to neoadjuvant nivolumab in non-metastatic clear cell renal cell carcinoma
Immune-Related Meningoencephalitis following Nivolumab in Metastatic Renal Cell Carcinoma
Response to anti-PD1 therapy with nivolumab in metastatic sarcomas
Activity of ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma
Activity of ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma
Significant response to nivolumab for metastatic chromophobe renal cell carcinoma with sarcomatoid differentiation: a case report
Successful Treatment with Nivolumab in a Patient with Metastatic Salivary Duct Carcinoma
Metastatic Merkel Cell Carcinoma of the Abdominal Wall
Cost Effectiveness of Avelumab for Metastatic Merkel Cell Carcinoma